These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 7836762

  • 1. Superantigen-induced human CD4+ helper/killer T cell phenomenon. Selective induction of Th1 helper/killer T cells and application to tumor immunotherapy.
    Kuge S, Miura Y, Nakamura Y, Mitomi T, Habu S, Nishimura T.
    J Immunol; 1995 Feb 15; 154(4):1777-85. PubMed ID: 7836762
    [Abstract] [Full Text] [Related]

  • 2. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
    Nishimura T, Nakamura Y, Takeuchi Y, Tokuda Y, Iwasawa M, Kawasaki A, Okumura K, Habu S.
    J Immunol; 1992 Jan 01; 148(1):285-91. PubMed ID: 1345787
    [Abstract] [Full Text] [Related]

  • 3. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
    Shu S, Krinock RA, Matsumura T, Sussman JJ, Fox BA, Chang AE, Terman DS.
    J Immunol; 1994 Feb 01; 152(3):1277-88. PubMed ID: 8301131
    [Abstract] [Full Text] [Related]

  • 4. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
    Dobashi H, Seki S, Habu Y, Ohkawa T, Takeshita S, Hiraide H, Sekine I.
    Hepatology; 1999 Aug 01; 30(2):430-6. PubMed ID: 10421651
    [Abstract] [Full Text] [Related]

  • 5. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
    Lando PA, Olsson C, Kalland T, Newton D, Kotb M, Dohlsten M.
    J Immunol; 1996 Oct 01; 157(7):2857-63. PubMed ID: 8816390
    [Abstract] [Full Text] [Related]

  • 6. [An efficient methods for the induction of human antitumor effector CD4+ and CD8+ T cells: their application to tumor immunotherapy].
    Nishimura T, Kuge S, Watanabe K, Lee U, Yahata T, Habu S.
    Hum Cell; 1994 Sep 01; 7(3):131-7. PubMed ID: 7873496
    [Abstract] [Full Text] [Related]

  • 7. Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen.
    Kuroda K, Yagi J, Imanishi K, Yan XJ, Li XY, Fujimaki W, Kato H, Miyoshi-Akiyama T, Kumazawa Y, Abe H, Uchiyama T.
    J Immunol; 1996 Aug 15; 157(4):1422-31. PubMed ID: 8759722
    [Abstract] [Full Text] [Related]

  • 8. Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma.
    Wang Q, Yu H, Ju DW, He L, Pan JP, Xia DJ, Zhang LH, Cao X.
    Gene Ther; 2001 Apr 15; 8(7):542-50. PubMed ID: 11319621
    [Abstract] [Full Text] [Related]

  • 9. Superantigens anergize cytokine production but not cytotoxicity in vivo.
    Sundstedt A, Dohlsten M, Hedlund G, Höidén I, Björklund M, Kalland T.
    Immunology; 1994 May 15; 82(1):117-25. PubMed ID: 7913912
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-18 regulates T helper 1 or 2 immune responses of human cord blood CD4+ V alpha 24+V beta 11+ natural killer T cells.
    Fujibayashi Y, Fujimori Y, Kasumoto I, Kai S, Hara H, Okamura H, Tsutsui H, Ogawa H, Nakanishi K.
    Int J Mol Med; 2007 Aug 15; 20(2):241-5. PubMed ID: 17611643
    [Abstract] [Full Text] [Related]

  • 11. Adenovirus-mediated intratumoral lymphotactin gene transfer potentiates the antibody-targeted superantigen therapy of cancer.
    Wang Q, Yu H, Zhang L, Ju D, Pan J, Xia D, Yao H, Zhang W, Wang J, Cao X.
    J Mol Med (Berl); 2002 Sep 15; 80(9):585-94. PubMed ID: 12226740
    [Abstract] [Full Text] [Related]

  • 12. Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell leukemia lines.
    Ihle J, Holzer U, Krull F, Dohlsten M, Kalland T, Niethammer D, Dannecker GE.
    Cancer Res; 1995 Feb 01; 55(3):623-8. PubMed ID: 7530598
    [Abstract] [Full Text] [Related]

  • 13. Staphylococcal enterotoxin B activates purified NK cells to secrete IFN-gamma but requires T lymphocytes to augment NK cytotoxicity.
    D'Orazio JA, Burke GW, Stein-Streilein J.
    J Immunol; 1995 Feb 01; 154(3):1014-23. PubMed ID: 7529788
    [Abstract] [Full Text] [Related]

  • 14. Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells.
    Li T, Harada M, Tamada K, Abe K, Nomoto K.
    Anticancer Res; 1997 Feb 01; 17(6D):4259-68. PubMed ID: 9494518
    [Abstract] [Full Text] [Related]

  • 15. Th1 development of naive CD4+ T cells is inhibited by co-activation with anti-CD4 monoclonal antibodies.
    Goedert S, Germann T, Hoehn P, Koelsch S, Palm N, Rüde E, Schmitt E.
    J Immunol; 1996 Jul 15; 157(2):566-73. PubMed ID: 8752903
    [Abstract] [Full Text] [Related]

  • 16. Killing of rat adenocarcinoma 13762 in situ by adoptive transfer of CD4+ anti-tumor T cells requires tumor expression of cell surface MHC class II molecules.
    Frey AB, Cestari S.
    Cell Immunol; 1997 May 25; 178(1):79-90. PubMed ID: 9184701
    [Abstract] [Full Text] [Related]

  • 17. Perforin and IFN-gamma are involved in the antitumor effects of antibody-targeted superantigens.
    Rosendahl A, Kristensson K, Hansson J, Riesbeck K, Kalland T, Dohlsten M.
    J Immunol; 1998 Jun 01; 160(11):5309-13. PubMed ID: 9605129
    [Abstract] [Full Text] [Related]

  • 18. Treatment of intracranial tumors by systemic transfer of superantigen-activated tumor-draining lymph node T cells.
    Inoue M, Plautz GE, Shu S.
    Cancer Res; 1996 Oct 15; 56(20):4702-8. PubMed ID: 8840987
    [Abstract] [Full Text] [Related]

  • 19. Signal requirement for induction of MHC-unrestricted antitumor cytotoxicity of human T cell CD4+/CD8+ subpopulations.
    Zhu HG, Klein-Franke A, Anderer FA.
    Anticancer Res; 1994 Oct 15; 14(3A):953-61. PubMed ID: 8074498
    [Abstract] [Full Text] [Related]

  • 20. Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes.
    Garcia-Mauriño S, Gonzalez-Haba MG, Calvo JR, Rafii-El-Idrissi M, Sanchez-Margalet V, Goberna R, Guerrero JM.
    J Immunol; 1997 Jul 15; 159(2):574-81. PubMed ID: 9218571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.